Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Shutterstock/JHVEPhoto
Lawsuit

Australian court upholds lawsuit against J&J for 'negligent' marketing of pelvic mesh implants

Worldwide, more than two million women have had the mesh products implanted in their bodies.

AN AUSTRALIAN COURT today upheld a landmark class-action lawsuit against Johnson & Johnson for “negligent” marketing of pelvic mesh implants, paving the way for thousands of women to receive compensation.

Johnson & Johnson had appealed the 2019 ruling that found the company guilty of “negligent” marketing and “deceptive conduct” while supplying thousands of pelvic meshes in Australia.

Victims said the mesh – designed to support weakened muscles holding up the pelvic organs – had caused disastrous side-effects including incontinence, infections and chronic pain.

“The risks were known, not insignificant, and on the respondents’ own admission, could cause significant and serious harm,” the judge said in the initial ruling.

A three-judge panel at the federal court dismissed the appeal today, a decision that “confirmed that these women are entitled to be compensated for the losses and the life-altering complications that they have suffered as a result of these implants,” said Rebecca Jancasukas, a lawyer for the claimants.

Shine Lawyers, which led the class action suit, said it would now vigorously pursue compensation claims possibly amounting to hundreds of millions of dollars.

The three women involved in the 2019 suit were awarded compensation ranging from Aus$556,000 (€357,000) to Aus$1.28 million (€821,980)).

The remaining members of the class action will now bring their own individual claims to court.

Responding to today’s ruling, Johnson & Johnson said it “empathises with all women who experience medical complications” but would review the court decision and “consider its options”.

Worldwide, more than two million women have had the mesh products implanted in their bodies and the Australian ruling is just one in a series globally.

The Mesh Survivors Ireland group has staged a number of protests at Leinster House to demand the State provide a structured pathway of specialist care for severe complications. 

It is unclear how many women have suffered complications after surgeries involving vaginal mesh implants in Ireland.

Early last year, a judge in California ordered Johnson & Johnson to pay $344 million (€288 million) for false and deceptive marketing of pelvic mesh products used by tens of thousands of women in the state.

The company has settled similar claims with the state of Washington for $9.9 million (€8.3m) and a coalition of 42 other states for $117 million (€98m).

Your Voice
Readers Comments
14
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel